Evidence map›Paper›PMID 34957159›Full record

ArticleFrontiers in medicine2021

Epidemiological Indicators of SARS-CoV-2 (COVID-19) and Vaccination Effectiveness on the Report of Positive Cases in the Colombian Army.

Maria Clara Duque, Camilo A Correa-Cárdenas, Sebastián Londoño-Méndez, Carolina Oliveros, Julie Pérez, Carlos D Daza, Lorena Albarracin, Elizabeth K Márquez, Maria T Alvarado, Frank De Los Santos Ortíz and 3 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria Clara DuqueLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Camilo A Correa-CárdenasLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Sebastián Londoño-MéndezSemillero Observatorio para la contención del COVID-19 en América Latina, Universidad del Rosario, Bogotá, Colombia.
Carolina OliverosLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Julie PérezLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Carlos D DazaLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Lorena AlbarracinLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Elizabeth K MárquezLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Maria T AlvaradoLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Frank De Los Santos OrtízLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Yanira RomeroLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Sergio Gutierrez-RiverosLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.
Claudia MéndezLaboratorio de Referencia e Investigación, Grupo de Investigación en Enfermedades Tropicales del Ejército (GINETEJ), Dirección de Sanidad Ejército, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The description of the epidemiological indicators of SARS-CoV-2 (COVID-19), such as the mortality rate (MR), the case fatality rate (CFR), and the attack rate (AR), as well as the geographical distribution and daily case reports, are used to evaluate the impact that this virus has had within the Colombian Army and its health system. As military forces around the world represent the force that defends sovereignty, independence, the integrity of the national territory, and the constitutional order, while maintaining migration controls in blocked border areas during this critical pandemic times, they must carry out strict epidemiological surveillance to control the situation among the servicemen. Up to date, the Colombian Army has faced a very high attack rate (AR = 8.55%) due, among others, to living conditions where active military personnel share bedrooms, bathrooms, and dining facilities, which facilitate the spread of the virus. However, being a mainly young and healthy population, the MR was 1.82 deaths/1,000 ha, while the CFR = 2.13% indexes consistently low if compared with those values reported for the national population. In addition, the effectiveness of vaccination is shown in daily cases of COVID-19, where, for the third peak, the active military population presented a decrease of positive patients compared to the dynamics of national transmission and the total population of the military forces (active, retired, and beneficiaries).

Indexed as

attack ratecase fatality rateColombiaepidemiologymilitary forcesmolecular and antigen diagnostic testsmortality rateSARS-CoV-2

Identifiers

PMID34957159
PMCPMC8695765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.